CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 33.25% | — | — | |
| 2 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 20.05% | — | — | |
| 3 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 12.68% | — | — | |
| 4 | CNST | Constellation Pharmaceutical | Stock-Other | 11.71% | — | -21.96% | |
| 5 | DVAX | Dynavax Technologies CORP | Stock-Other | 5.21% | — | +3.29% | |
| 6 | REPL | Replimune Group INC | Stock-Other | 4.79% | — | — | |
| 7 | SVRA | Savara INC | Stock-Other | 3.89% | +0.54% | — | |
| 8 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 2.79% | — | — | |
| 9 | MRNSUSD | Marinus Pharmaceuticals INC | Stock-Other | 2.04% | — | — | |
| 10 | ✓ | Aptinyx INC | Stock-Other | 2.03% | — | +149.81% | |
| 11 | SLDB | Solid Biosciences Inc. | Stock-Other | 1.56% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Aptinyx INC | +0.9% | +149.81% | Add |
| 2 | SVRA | Savara INC | +0.5% | — | Unchanged |
| 3 | ASNSUSD | X4 Pharmaceuticals INC | +0.2% | — | Unchanged |
| 4 | MRNSUSD | Marinus Pharmaceuticals INC | +0.1% | — | Unchanged |
| 5 | DRNAUSD | Dicerna Pharmaceuticals INC | -0.7% | — | Unchanged |
| 6 | SLDB | Solid Biosciences Inc. | -1% | — | Unchanged |
| 7 | REPL | Replimune Group INC | -1.3% | — | Unchanged |
| 8 | DVAX | Dynavax Technologies CORP | -2% | +3.29% | Add |
| 9 | CNST | Constellation Pharmaceutical | -8.1% | -21.96% | Trim |
| 10 | SWTXUSD | Springworks Therapeutics INC | -8.6% | — | Unchanged |
| 11 | ARQT | Arcutis Biotherapeutics INC | — | NEW | New buy |